Policy changes Backwork has recorded, newest first. The most recent change on record is from October 11, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
82,244 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Blinatumomab (e.g., Blincyto) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Bimatoprost (e.g., Durysta) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Bevacizumab (e.g., Avastin) and Biosimilars for Ophthalmic Use | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Bevacizumab (e.g., Avastin) and Biosimilars for Oncologic Indications | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Bevacizumab (e.g., Avastin) and Biosimilars for Non-Oncologic and Non-Ophthalmologic Indications | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Belimumab (e.g., Benlysta) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Belantamab mafodotin-blmf (e.g., Blenrep) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Axicabtagene Ciloleucel (e.g., Yescarta) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Axatilimab (e.g., Niktimvo) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Avelumab (e.g., Bavencio) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Avalglucosidase alfa-ngpt (e.g., Nexviazyme) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Avacincaptad pegol (e.g., Izervay) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Atezolizumab and Atezolizumab with Hyaluronidase (e.g., Tecentriq and Tecentriq Hybreza) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Asparagine Specific Enzymes (e.g., Rylaze, Asparlas, Oncaspar) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Anti-tissue Factor Pathway Inhibitors [Marstacimab-hncq (e.g., Hympavzi) and Concizumab-mtci (e.g., Alhemo)] | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Anifrolumab-fnia (e.g., Saphnelo) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Amivantamab-vmjw (e.g., Rybrevant) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Alpha-1 Proteinase Inhibitor Therapy (e.g., Aralast, Glassia, Prolastin, and Zemaira) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Alglucosidase alfa (e.g., Lumizyme) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Alemtuzumab (e.g., Lemtrada) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Afamitresgene autoleucel (e.g., Tecelra) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Tisagenlecleucel (e.g., Kymriah) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Ado-Trastuzumab Emtansine (e.g., Kadcyla (Trastuzumab-DM1)) for Treatment of HER-2 Positive Malignancies | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | ADAMTS13, recombinant-krhn (e.g., Adzynma) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Abatacept (e.g., Orencia) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Sirolimus protein-bound particles for injectable suspension (e.g., Fyarro) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Zenocutuzumab-zbco (Bizengri) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Zanidatamab-hrii (Ziihera) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Velmanase alfa (Lamzede) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Vedolizumab (Entyvio) for Injection for Intravenous Use | Codes changed |
| Aug 22, 2026 | AmeriHealth | Ustekinumab for Intravenous Use | Codes changed |
| Aug 22, 2026 | AmeriHealth | Ublituximab-xiiy (Briumvi ) for intravenous use | Codes changed |
| Aug 22, 2026 | AmeriHealth | Trilaciclib (Cosela) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Triamcinolone Acetonide ER Injectable (Zilretta) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Trastuzumab (Herceptin) and Related Biosimilars, Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Toripalimab-tpzi (Loqtorzi) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Tisotumab vedotin-tftv (Tivdak) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Tislelizumab-jsgr (Tevimbra) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Tildrakizumab-asmn (Ilumya) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Tezepelumab-ekko (Tezspire) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Teprotumumab (Tepezza) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Teplizumab-mzwv (Tzield) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Telisotuzumab vedotin-tllv (Emrelis) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Teclistamab-cqyv (Tecvayli) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Tebentafusp-tebn (Kimmtrak) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Tarlatamab-dlle (Imdelltra for intravenous use | Codes changed |
| Aug 22, 2026 | AmeriHealth | Talquetamab-tgvs (Talvey) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Tafasitamab-cxix (Monjuvi) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Sutimlimab-jome (Enjaymo) | Codes changed |
| Aug 22, 2026 | AmeriHealth | Spesolimab-sbzo (Spevigo) | Codes changed |